These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 22496848)
1. Reduced axonal transport and increased excitotoxic retinal ganglion cell degeneration in mice transgenic for human mutant P301S tau. Bull ND; Guidi A; Goedert M; Martin KR; Spillantini MG PLoS One; 2012; 7(4):e34724. PubMed ID: 22496848 [TBL] [Abstract][Full Text] [Related]
2. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma. Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768 [TBL] [Abstract][Full Text] [Related]
3. Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability. Gasparini L; Crowther RA; Martin KR; Berg N; Coleman M; Goedert M; Spillantini MG Neurobiol Aging; 2011 Mar; 32(3):419-33. PubMed ID: 19356824 [TBL] [Abstract][Full Text] [Related]
4. Tau accumulation in the retina promotes early neuronal dysfunction and precedes brain pathology in a mouse model of Alzheimer's disease. Chiasseu M; Alarcon-Martinez L; Belforte N; Quintero H; Dotigny F; Destroismaisons L; Vande Velde C; Panayi F; Louis C; Di Polo A Mol Neurodegener; 2017 Aug; 12(1):58. PubMed ID: 28774322 [TBL] [Abstract][Full Text] [Related]
5. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies. Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925 [TBL] [Abstract][Full Text] [Related]
6. Evidence for accelerated tauopathy in the retina of transgenic P301S tau mice exposed to repetitive mild traumatic brain injury. Xu L; Ryu J; Nguyen JV; Arena J; Rha E; Vranis P; Hitt D; Marsh-Armstrong N; Koliatsos VE Exp Neurol; 2015 Nov; 273():168-76. PubMed ID: 26311071 [TBL] [Abstract][Full Text] [Related]
7. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice. Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748 [TBL] [Abstract][Full Text] [Related]
8. Mutant three-repeat tau expression initiates retinal ganglion cell death through Caspase-2. Ngolab J; Canchi S; Rasool S; Elmaarouf A; Thomas K; Sarsoza F; Grundman J; Mante M; Florio J; Nandankar N; Korouri S; Zago W; Masliah E; Rissman RA Neurobiol Dis; 2021 May; 152():105277. PubMed ID: 33516874 [TBL] [Abstract][Full Text] [Related]
9. Piericidin A aggravates Tau pathology in P301S transgenic mice. Höllerhage M; Deck R; De Andrade A; Respondek G; Xu H; Rösler TW; Salama M; Carlsson T; Yamada ES; Gad El Hak SA; Goedert M; Oertel WH; Höglinger GU PLoS One; 2014; 9(12):e113557. PubMed ID: 25437199 [TBL] [Abstract][Full Text] [Related]
10. Tau modulation through AAV9 therapy augments Akt/Erk survival signalling in glaucoma mitigating the retinal degenerative phenotype. Thananthirige KPM; Chitranshi N; Basavarajappa D; Rajput R; Abbasi M; Palanivel V; Gupta VB; Paulo JA; Koronyo-Hamaoui M; Mirzaei M; Graham SL; Gupta V Acta Neuropathol Commun; 2024 Jun; 12(1):89. PubMed ID: 38845058 [TBL] [Abstract][Full Text] [Related]
11. Tau pathology is present in vivo and develops in vitro in sensory neurons from human P301S tau transgenic mice: a system for screening drugs against tauopathies. Mellone M; Kestoras D; Andrews MR; Dassie E; Crowther RA; Stokin GB; Tinsley J; Horne G; Goedert M; Tolkovsky AM; Spillantini MG J Neurosci; 2013 Nov; 33(46):18175-89. PubMed ID: 24227726 [TBL] [Abstract][Full Text] [Related]
12. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions. Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256 [TBL] [Abstract][Full Text] [Related]
13. A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation. Ajit D; Trzeciakiewicz H; Tseng JH; Wander CM; Chen Y; Ajit A; King DP; Cohen TJ J Biol Chem; 2019 Nov; 294(45):16698-16711. PubMed ID: 31543505 [TBL] [Abstract][Full Text] [Related]
14. Global axonal transport rates are unaltered in htau mice in vivo. Yuan A; Kumar A; Sasaki T; Duff K; Nixon RA J Alzheimers Dis; 2013; 37(3):579-86. PubMed ID: 23948900 [TBL] [Abstract][Full Text] [Related]
15. Axonal transport rates in vivo are unaffected by tau deletion or overexpression in mice. Yuan A; Kumar A; Peterhoff C; Duff K; Nixon RA J Neurosci; 2008 Feb; 28(7):1682-7. PubMed ID: 18272688 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin attenuates the progression of tau pathology in P301S tau transgenic mice. Ozcelik S; Fraser G; Castets P; Schaeffer V; Skachokova Z; Breu K; Clavaguera F; Sinnreich M; Kappos L; Goedert M; Tolnay M; Winkler DT PLoS One; 2013; 8(5):e62459. PubMed ID: 23667480 [TBL] [Abstract][Full Text] [Related]
17. Roscovitine, a Cyclin-Dependent Kinase-5 Inhibitor, Decreases Phosphorylated Tau Formation and Death of Retinal Ganglion Cells of Rats after Optic Nerve Crush. Hirokawa T; Horie T; Fukiyama Y; Mimura M; Takai S; Kida T; Oku H Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360858 [TBL] [Abstract][Full Text] [Related]
18. Assembly of transgenic human P301S Tau is necessary for neurodegeneration in murine spinal cord. Macdonald JA; Bronner IF; Drynan L; Fan J; Curry A; Fraser G; Lavenir I; Goedert M Acta Neuropathol Commun; 2019 Mar; 7(1):44. PubMed ID: 30885267 [TBL] [Abstract][Full Text] [Related]
19. Age-dependent axonal transport and locomotor changes and tau hypophosphorylation in a "P301L" tau knockin mouse. Gilley J; Seereeram A; Ando K; Mosely S; Andrews S; Kerschensteiner M; Misgeld T; Brion JP; Anderton B; Hanger DP; Coleman MP Neurobiol Aging; 2012 Mar; 33(3):621.e1-621.e15. PubMed ID: 21492964 [TBL] [Abstract][Full Text] [Related]
20. Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein. Yin Z; Valkenburg F; Hornix BE; Mantingh-Otter I; Zhou X; Mari M; Reggiori F; Van Dam D; Eggen BJL; De Deyn PP; Boddeke E J Alzheimers Dis; 2017; 60(s1):S41-S57. PubMed ID: 28222529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]